233 related articles for article (PubMed ID: 18806742)
1. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
Sakin V; Eskiocak U; Kars MD; Iseri OD; Gunduz U
Exp Oncol; 2008 Sep; 30(3):202-5. PubMed ID: 18806742
[TBL] [Abstract][Full Text] [Related]
2. Drug resistant breast cancer cells overexpress ETS1 gene.
Kars MD; Işeri OD; Gündüz U
Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
[TBL] [Abstract][Full Text] [Related]
3. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Geng M; Yin YC; Cao YC; Fu ZJ; Wang XY; Tai YH
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):838-41. PubMed ID: 18396642
[TBL] [Abstract][Full Text] [Related]
5. Effect of antineoplastic agents on the expression of human telomerase reverse transcriptase beta plus transcript in MCF-7 cells.
Spiropoulou T; Ferekidou L; Angelopoulou K; Stathopoulou A; Talieri M; Lianidou ES
Clin Biochem; 2004 Apr; 37(4):299-304. PubMed ID: 15003732
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins.
Işeri OD; Kars MD; Arpaci F; Gündüz U
Cancer Chemother Pharmacol; 2010 Feb; 65(3):447-55. PubMed ID: 19543729
[TBL] [Abstract][Full Text] [Related]
7. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
[TBL] [Abstract][Full Text] [Related]
8. A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells.
Kars MD; Işeri OD; Gündüz U
Eur J Pharmacol; 2011 Apr; 657(1-3):4-9. PubMed ID: 21320484
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
13. Effect of doxorubicin on telomerase activity and apoptotic gene expression in doxorubicin-resistant and -sensitive MCF-7 cells: an experimental study.
Eskiocak U; Işeri OD; Kars MD; Biçer A; Gunduz U
Chemotherapy; 2008; 54(3):209-16. PubMed ID: 18560228
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A
Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S
Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718
[TBL] [Abstract][Full Text] [Related]
16. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
17. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
18. Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells.
Ishikawa T; Kamiyama M; Hisatomi H; Ichikawa Y; Momiyama N; Hamaguchi Y; Hasegawa S; Narita T; Shimada H
Cancer Lett; 1999 Jul; 141(1-2):187-94. PubMed ID: 10454261
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells.
Yu M; Shi Y; Wei X; Yang Y; Zang F; Niu R
Eur J Cancer Prev; 2009 Nov; 18(6):445-57. PubMed ID: 19609211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
